Tag: Novo Nordisk
-
Ozempic Vision Loss Lawsuits Have Been Filed by Patients Against Novo Nordisk
We List Some of the Legal Liability Allegations Regarding Drug Company Actions and Failures (Posted by Tom Lamb at Drug Injury Watch) During the past several weeks, Ozempic vision loss lawsuits have been filed by…
-
March 2025 Medical Article About Blindness or Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
Discusses Timing for Increased Risk of Semaglutide-related Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Side Effect (Posted by Tom Lamb at Drug Injury Watch) On March 27, 2025, the JAMA Ophthalmology medical journal published a report…
-
Ozempic Vision Problems From Semaglutide Apply to Wegovy and Rybelsus, Also
NAION Eye Side Effect Risk Increased With Semaglutide Drugs – Two Recent Medical Studies (Posted by Tom Lamb at Drug Injury Watch) UPDATE: The [European Medicines Agency (EMA)] Pharmacovigilance Risk Assessment Committee (PRAC) reviewed all available…
-
Novo Nordisk Semaglutide Drug Ozempic Linked to Vision Loss, Doubling the Risk: December 2024 Update
European Drug Regulators Are Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU…
-
Ozempic, Wegovy, Other GLP-1 Semaglutide Weight-Loss Drugs Linked to Gastroparesis in Recent Medical Study
Researchers Compared Semaglutide Drugs, Such as Ozempic and Wegovy, to Contrave, a Non-GLP-1 Drug, in Weight-Loss Patients (Posted by Tom Lamb at Drug Injury Watch) An October 2023 medical journal article presented the results of…
-
Severe Stomach Conditions in Patients Using Semaglutide Weight Loss Drugs From Novo Nordisk
Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis (Posted by Tom Lamb at Drug Injury Watch) Semaglutide is the active ingredient in three Novo Nordisk drugs that are being used…
-
Diet Drug Saxenda May Increase Pancreatic Cancer Risks For Patients Only Wanting Weight Loss
Saxenda Dose Contains Twice As Much Liraglutide As Diabetes Medicine Victoza, Also Linked To Malignancy In Pancreas (Posted by Tom Lamb at DrugInjuryWatch.com) In 2014, the FDA approved Saxenda (liraglutide) for the…
-
Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice
FDA Letters To AstraZeneca And Novo Nordisk Approve Addition Of Information About Increased Risk For Medullary Thyroid Carcinoma (MTC) (Posted by Tom Lamb at DrugInjuryWatch.com) The diabetes drugs Bydureon (exenatide extended-release) for injectable suspension and Victoza (liraglutide…
-
The Drug-Induced Pancreatitis Safety Problem That Hangs Around Victoza Gets Another Look
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new…